Use of teicoplanin in preterm neonates with staphylococcal late-onset neonatal sepsis

被引:8
|
作者
Degraeuwe, PLJ
Beuman, GH
van Tiel, FH
Maertzdorf, WJ
Blanco, CE
机构
[1] Univ Hosp Maastricht, Dept Paediat, NL-6202 AZ Maastricht, Netherlands
[2] Univ Hosp Maastricht, Dept Clin Pharm, NL-6202 AZ Maastricht, Netherlands
[3] Univ Hosp Maastricht, Dept Clin Microbiol, NL-6202 AZ Maastricht, Netherlands
来源
BIOLOGY OF THE NEONATE | 1998年 / 73卷 / 05期
关键词
teicoplanin; pharmacology; adverse effects; Gram-positive bacterial infections; drug therapy;
D O I
10.1159/000013987
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: To study the clinical pharmacology of teicoplanin in babies admitted to a newborn intensive care unit, by monitoring serum levels, efficacy and potential side effects. Methods: An open, nonrandomized descriptive study was performed in the neonatal intensive and high care unit of the University Hospital Maastricht, The Neterlands. Twenty-three preterm neonates, gestational age ranging from 26 to 32 weeks (median 28.4 weeks), postnatal age from 5 to 47 days, and birth weight from 570 to 1,740 g, presenting with (suspected) late onset septicemia, were studied. Of 21 culture-proven septicemias, 20 were caused by staphylococci. The teicoplanin loading dose was 15 mg/kg i.v., followed by a maintenance dose of 8 mg/kg every 24 h. Intravenous gentamicin was also administered pending blood culture. Serum teicoplanin concentrations were measured by fluorescence polarization immunoassay. Clinical and microbiological cure/failure rates were determined and possible side effects were monitored. Results: The study of individual pharmacokinetics during multiple-dose intravenous infusions was rendered impossible by apparently inaccurate dosing. Peak (30 min after end of the infusion) and trough teicoplanin levels were stable throughout the study and averaged 27.8 (interquartile range 23.7-32.9) and 12.3 (interquartile range 9.1-16.8) mg/l, respectively. The microbiological and clinical cure rates were 90% in gram-positive septicemia. There was no apparent toxicity. Conclusions: Inaccurate drug administration was a problem in this study, making a multidose pharmacokinetic study impossible. It is possible that inaccurate drug administration and not current dosage guidelines yielded trough levels below 10 mg/l in 57 (32%) of 176 instances. This pharmaceutical aspect clearly warrants further study. However, microbiological and clinical cure rates were high in gram-positive septicemias, No side effects attributable to teicoplanin therapy were encountered.
引用
收藏
页码:287 / 294
页数:8
相关论文
共 50 条
  • [1] Knowledge gaps in late-onset neonatal sepsis in preterm neonates: a roadmap for future research
    Kurul, Serife
    Fiebig, Kinga
    Flint, Robert B.
    Reiss, Irwin K. M.
    Kuster, Helmut
    Simons, Sinno H. P.
    Voller, Swantje
    Taal, H. Rob
    PEDIATRIC RESEARCH, 2022, 91 (02) : 368 - 379
  • [2] Knowledge gaps in late-onset neonatal sepsis in preterm neonates: a roadmap for future research
    Serife Kurul
    Kinga Fiebig
    Robert B. Flint
    Irwin K. M. Reiss
    Helmut Küster
    Sinno H. P. Simons
    Swantje Voller
    H. Rob Taal
    Pediatric Research, 2022, 91 : 368 - 379
  • [3] Zinc Supplementation in Preterm Neonates with Late-Onset Sepsis: Is It Beneficial?
    Elfarargy, Mohamed Shawky
    Al-Ashmawy, Ghada
    Abu-Risha, Sally
    Khattab, Haidy
    AMERICAN JOURNAL OF PERINATOLOGY, 2022, 39 (10) : 1097 - 1103
  • [4] Inflammation, sepsis severity and neurodevelopmental outcomes of late-onset sepsis in preterm neonates
    Kurul, Serife
    Beckers, Famke L. M.
    Vermeulen, Marijn J.
    Suurland, Jill
    Hasbek, Jasmin E.
    Ramakers, Christian R. B.
    Simons, Sinno H. P.
    Reiss, Irwin K. M.
    Taal, H. Rob
    PEDIATRIC RESEARCH, 2023, 94 (06) : 2026 - 2032
  • [5] Inflammation, sepsis severity and neurodevelopmental outcomes of late-onset sepsis in preterm neonates
    Şerife Kurul
    Famke L. M. Beckers
    Marijn J. Vermeulen
    Jill Suurland
    Jasmin E. Hasbek
    Christian R. B. Ramakers
    Sinno H. P. Simons
    Irwin K. M. Reiss
    H. Rob Taal
    Pediatric Research, 2023, 94 : 2026 - 2032
  • [6] Unusual presentation of late-onset disseminated staphylococcal sepsis in a preterm infant
    Khattak, Shahzad Gul
    Dady, Ian
    Mukherjee, Devdeep
    BMJ CASE REPORTS, 2019, 12 (03)
  • [7] Role of presepsin in the diagnosis of late-onset neonatal sepsis in preterm infants
    Topcuoglu, Sevilay
    Arslanbuga, Cansev
    Gursoy, Tugba
    Aktas, Alev
    Karatekin, Guner
    Uluhan, Ramazan
    Ovali, Fahri
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2016, 29 (11): : 1834 - 1839
  • [8] Carboxyhemoglobin Levels in Preterm Neonatal Late-Onset Sepsis: to Predict or not to Predict
    Vardar, Gonca
    Ozek, Eren
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2023, 15
  • [9] PREDICTIVE VALUE OF CLINICAL SIGNS IN LATE-ONSET SEPSIS (LOS) IN PRETERM NEONATES
    Bekhof, J.
    Van Straaten, I.
    Kok, J.
    PEDIATRIC RESEARCH, 2010, 68 : 265 - 265
  • [10] Blood pressure, organ dysfunction, and mortality in preterm neonates with late-onset sepsis
    Faith Zhu
    Michelle Baczynski
    Ashraf Kharrat
    Xiang Y. Ye
    Dany Weisz
    Amish Jain
    Pediatric Research, 2022, 92 : 498 - 504